They received the drug for seven days at a dose of 200 mg daily. A block of synthesis was demonstrated in vitro. Insurers typically require symptoms plus two low morning testosterone results and periodic labs. Work with your clinician to review opioids, glucocorticoids, ketoconazole, spironolactone, and certain antidepressants. Keep alcohol moderate (≤2 drinks/day, with alcohol‑free days each week). As with all azole antifungal agents, ketoconazole works principally by inhibiting the enzyme cytochrome P450 14α-demethylase (CYP51A1). A subsequent trial in Europe failed to show a risk to infants of mothers receiving ketoconazole. It should be used for the treatment of certain fungal infections, known as endemic mycoses, only when alternative antifungal therapies are not available or not tolerated. Oral ketoconazole at a dosage range of 400 to 2,000 mg/day has been found to result in a rate of gynecomastia of 21%. In any case, the risk of hepatotoxicity with ketoconazole limits its use in all of these indications, especially in those that are benign such as hirsutism. Most clinicians aim for mid‑normal total testosterone (often ~400–700 ng/dL), individualized to symptom control and side effects. For oral TU, plan regular blood pressure monitoring. The 2023 TRAVERSE trial in high‑risk men found testosterone was non‑inferior to placebo for major cardiac events over follow‑up, though there were slightly higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury. If you’re trying to conceive, avoid standard testosterone, it suppresses sperm production. Oral levoketoconazole may have a lower risk of liver toxicity than oral ketoconazole. Second, ketoconazole is an androgen receptor antagonist, competing with androgens such as testosterone and dihydrotestosterone (DHT) for binding to the androgen receptor. In the event of an overdose of oral ketoconazole, treatment should be supportive and based on symptoms. The side effects of ketoconazole are sometimes harnessed in the treatment of non-fungal conditions. Ketoconazole is used orally in dosages of 200 to 400 mg per day in the treatment of superficial and deep fungal infections. Fifty percent displacement of 3HR1881 binding to AR was achieved by 6.4 +/- 1.8 (SE) x 10(-5) M ketoconazole. Ketoconazole competition with 3Hmethyltrienolone (R1881) for androgen binding sites in dispersed, intact cultured human skin fibroblasts was determined at 22 degrees C. Oral ketoconazole has been replaced with oral fluconazole or itraconazole for many mycoses. Following its introduction, ketoconazole was the only systemic antifungal available for almost a decade. Studies in postmenopausal women with breast cancer have found that ketoconazole significantly decreases androstenedione levels, slightly decreases estradiol levels, and does not affect estrone levels.
